BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 26415635)

  • 1. Does LLETZ excision margin status predict residual disease in women who have undergone post-treatment cervical cytology and high-risk human papillomavirus testing?
    Palmer JE; Ravenscroft S; Ellis K; Crossley J; Dudding N; Smith JH; Tidy JA
    Cytopathology; 2016 Jun; 27(3):210-7. PubMed ID: 26415635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
    van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small lesion size measured by colposcopy may predict absence of cervical intraepithelial neoplasia in a large loop excision of the transformation zone specimen.
    Munmany M; Marimon L; Cardona M; Nonell R; Juiz M; Astudillo R; Ordi J; Torné A; Del Pino M
    BJOG; 2017 Feb; 124(3):495-502. PubMed ID: 27506510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-risk HPV platforms and test of cure: should specific HPV platforms more suited to screening in a 'test of cure' scenario be recommended?
    Innamaa A; Dudding N; Ellis K; Crossley J; Smith JH; Tidy JA; Palmer JE
    Cytopathology; 2015 Dec; 26(6):381-7. PubMed ID: 25412857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2-3 after treatment with a large loop excision of the transformation zone: a retrospective study.
    Fernández-Montolí ME; Tous S; Medina G; Castellarnau M; García-Tejedor A; de Sanjosé S
    BJOG; 2020 Feb; 127(3):377-387. PubMed ID: 31631477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive factors for residual disease in the uterine cervix after large loop excision of the transformation zone in patients with cervical intraepithelial neoplasia III.
    Hamontri S; Israngura N; Rochanawutanon M; Bullangpoti S; Tangtrakul S
    J Med Assoc Thai; 2010 Feb; 93 Suppl 2():S74-80. PubMed ID: 21299083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indication and outcome of repeat large loop excision biopsies of the cervix.
    Moss EL; Appleyard TL; Winning JM; Jones PW; Luesley DM
    J Low Genit Tract Dis; 2011 Apr; 15(2):89-92. PubMed ID: 21169867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical relevance of excisional margins after large loop excision of the transformation zone for the persistence of cervical dysplasia.
    Reijntjes B; Eising M; Kleppe M; Geuken E; Woolderink JM
    Int J Gynaecol Obstet; 2023 Oct; 163(1):140-147. PubMed ID: 37243333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus test with cytology triage in organized screening for cervical cancer.
    Veijalainen O; Kares S; Kujala P; Tirkkonen M; Vuento R; Kholová I; Luukkaala T; Osuala V; Mäenpää J
    Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1220-1227. PubMed ID: 27591407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical intraepithelial neoplasia in women with transformation zone type 3: cervical biopsy versus large loop excision.
    Gustafson LW; Hammer A; Bennetsen MH; Kristensen CB; Majeed H; Petersen LK; Andersen B; Bor P
    BJOG; 2022 Dec; 129(13):2132-2140. PubMed ID: 35488417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Wait-and-see policy versus loop excision after two consecutive Pap-2 cervical smears: over time less surgery and an equivalent outcome; no substantial contribution to be expected from the detection of high risk human papillomavirus].
    Bekkers RL; Hanselaar AG; Melchers WJ; van Schaik JH; Boonstra H; Massuger LF
    Ned Tijdschr Geneeskd; 2003 Feb; 147(7):302-6. PubMed ID: 12622008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
    Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
    BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is colposcopy necessary at twelve months after large loop excision of the transformation zone? A clinical audit.
    Thompson V; Marin R
    Aust N Z J Obstet Gynaecol; 2013 Dec; 53(6):571-3. PubMed ID: 24289063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of HPV cervical screening on negative large loop excision of the transformation zone (LLETZ): A comparative cohort study.
    Manley KM; Wills AK; Morris GC; Hogg JL; López Bernal A; Murdoch JB
    Gynecol Oncol; 2016 Jun; 141(3):485-491. PubMed ID: 27032376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with HPV persistence after treatment for high-grade cervical intra-epithelial neoplasia with large loop excision of the transformation zone (LLETZ).
    Sarian LO; Derchain SF; Pitta Dda R; Morais SS; Rabelo-Santos SH
    J Clin Virol; 2004 Dec; 31(4):270-4. PubMed ID: 15494268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of cervical intraepithelial neoplasia (CIN) with colposcopic biopsy and efficacy of loop electrosurgical excision procedure (LEEP).
    Duesing N; Schwarz J; Choschzick M; Jaenicke F; Gieseking F; Issa R; Mahner S; Woelber L
    Arch Gynecol Obstet; 2012 Dec; 286(6):1549-54. PubMed ID: 22865036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low recurrence rate of high-grade cervical intraepithelial neoplasia after successful excision and routine colposcopy during follow-up.
    Lili E; Chatzistamatiou K; Kalpaktsidou-Vakiani A; Moysiadis T; Agorastos T
    Medicine (Baltimore); 2018 Jan; 97(4):e9719. PubMed ID: 29369205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis.
    Arbyn M; Redman CWE; Verdoodt F; Kyrgiou M; Tzafetas M; Ghaem-Maghami S; Petry KU; Leeson S; Bergeron C; Nieminen P; Gondry J; Reich O; Moss EL
    Lancet Oncol; 2017 Dec; 18(12):1665-1679. PubMed ID: 29126708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test of cure and beyond: superiority of thermal ablation over LLETZ in the treatment of high-grade CIN.
    Armstrong GM; Ragupathy K
    Arch Gynecol Obstet; 2022 Nov; 306(5):1815-1820. PubMed ID: 35107616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity of high-risk HPV Hybrid Capture II (hrHPV HC2) test using SurePath(TM) specimens in the prediction of cervical high-grade squamous lesions.
    Zhou F; Pulinthanathu R; Elgert P; Cangiarella J; Simsir A
    Diagn Cytopathol; 2015 May; 43(5):381-7. PubMed ID: 25546355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.